---
layout: minimal-medicine
title: Terlipressin
---

# Terlipressin
### Generic Name
Terlipressin

### Usage
Terlipressin is primarily used in two critical situations:

1. **Management of Esophageal Varices Bleeding:** This is a serious complication of liver disease where enlarged veins in the esophagus rupture, causing potentially life-threatening bleeding. Terlipressin helps control this bleeding by constricting blood vessels, reducing blood flow to the varices, and thus decreasing bleeding.

2. **Treatment of Hepatorenal Syndrome Type 1 (HRS-1):** HRS-1 is a severe kidney failure complication in patients with advanced liver disease.  Terlipressin helps improve kidney function in these patients by constricting blood vessels, thus altering blood flow dynamics and potentially reversing the kidney damage.  It is also used in the setting of hepatorenal syndrome-acute kidney injury.

### Dosage

**Important Note:** The following dosage information is for general knowledge and should not be considered medical advice.  Always follow the instructions provided by your doctor or pharmacist.  Dosage may vary based on individual patient factors and response to treatment.

**Esophageal Varices Bleeding (IV):**

* **Initial Dose:**  There are two common approaches:
    * A standard 2mg dose every 4 hours until bleeding is controlled for at least 24 hours (or up to a maximum of 48 hours).
    * A weight-based approach: 1 mg for patients under 50kg, 1.5 mg for patients weighing 50-70kg, and 2 mg for patients over 70kg, every 4 hours until bleeding is controlled for at least 24 hours (or up to a maximum of 48 hours).
* **Maintenance Dose:** If bleeding is controlled, a lower maintenance dose of 1 mg every 4-6 hours may be given for 2-5 days.


**Hepatorenal Syndrome Type 1 (HRS-1) or Hepatorenal Syndrome-Acute Kidney Injury (IV):**

* **Initial Dose (Days 1 & 2):** 1 mg every 4-6 hours (bolus injection) or 2 mg per 24 hours as a continuous infusion.
* **Dosage Adjustment (Day 3 Onwards):** If there's not at least a 25% reduction in baseline serum creatinine after 2 days, the dose may be gradually increased to a maximum of 2 mg every 4-6 hours (bolus) or 12 mg per 24 hours (continuous infusion).
* **Duration of Therapy:** Treatment is continued for a maximum of 14 days, or until a complete response is achieved (serum creatinine <1.5 mg/dL [133 μmol/L] or within 0.3 mg/dL [26.5 μmol/L] of baseline). Treatment should be stopped if there's no improvement in serum creatinine after 7 days, or if dialysis or liver transplant is needed.


**Dosage Adjustments:**  No specific dosage adjustments are typically needed for hepatic or renal impairment, but caution is advised, particularly in patients with renal impairment.  Your doctor will make the decision.  If adverse effects occur, temporary treatment interruption, followed by a lower dose or less frequent administration, may be considered.


### Side Effects

**Common Side Effects:**

* Vomiting
* Abdominal pain
* Bronchospasm/wheezing
* Headache
* Anxiety

**Less Common but Serious Side Effects:**

* Hypotension (low blood pressure)
* Hypertension (high blood pressure)
* Cardiac arrhythmias (irregular heartbeat)
* Skin necrosis (tissue death)
* Ischemic events (reduced blood flow to tissues)
*  Sepsis (blood infection)
*  Multiorgan failure

If you experience any of these side effects, especially the serious ones, contact your healthcare provider immediately.


### How it Works

Terlipressin is a synthetic analogue of vasopressin, a hormone that constricts blood vessels. While terlipressin has limited direct activity, it is slowly converted in the body to lysine vasopressin, which is a more potent vasoconstrictor. This constriction of blood vessels reduces blood flow to the esophagus's varices, thereby reducing bleeding. In HRS-1, the vasoconstriction helps to regulate blood flow to the kidneys, aiding in the restoration of kidney function.

### Precautions

* **Contraindications:** Terlipressin is contraindicated in patients with hypersensitivity to terlipressin or any component of the formulation, during pregnancy, and in cases of septic shock with low cardiac output.
* **Drug Interactions:** Terlipressin can interact with certain medications, potentially increasing the risk of bradycardia (slow heart rate), QT prolongation (an ECG abnormality linked to heart rhythm issues), and other adverse effects.  It is crucial to inform your healthcare provider about all medications you are taking.
* **Warnings:**  Terlipressin should be used with caution in patients with pre-existing heart conditions (arrhythmias, coronary artery disease, etc.), peripheral vascular disease, uncontrolled hypertension, or respiratory issues.  Older adults and patients with hypovolemia (low blood volume) also require close monitoring.


### FAQs

* **Q: How is Terlipressin stored?** A: Store Terlipressin as directed by your pharmacist or healthcare provider. Usually, this means keeping it at room temperature, away from light and moisture.

* **Q: Can I stop taking Terlipressin if I feel better?** A: No, do not stop taking Terlipressin without consulting your doctor.  Stopping abruptly could worsen your condition.

* **Q: Is Terlipressin safe for pregnant women?** A: No, Terlipressin is contraindicated in pregnancy.

* **Q:  What should I do if I miss a dose?** A:  Contact your doctor or pharmacist as soon as possible for guidance. Never double a dose to make up for a missed one.

* **Q: Are there any long-term effects associated with Terlipressin?** A: The long-term effects of Terlipressin are not fully established, and usage is typically limited to short-term treatment of acute conditions.  Your doctor will monitor you for any potential long-term complications.

**Disclaimer:** This information is for educational purposes only and should not be considered medical advice.  Always consult your physician or healthcare provider for any health concerns or before making any decisions related to your health or treatment.
